Today: 9 June 2026
Qualcomm (QCOM) stock rises after-hours on Google auto AI pact, CES chip launches

Qualcomm (QCOM) stock rises after-hours on Google auto AI pact, CES chip launches

New York, Jan 6, 2026, 19:42 EST — After-hours

  • Qualcomm shares rose about 3.5% in extended trade as CES announcements put its auto and PC push back in focus.
  • Qualcomm and Google detailed a deeper automotive tie-up aimed at speeding “software-defined vehicles” and in-car AI agents.
  • Investors are watching for more CES design-win headlines and Qualcomm’s Feb. 4 earnings call for guidance.

Qualcomm Incorporated shares rose 3.5% to $182.45 in after-hours trading on Tuesday, after swinging between $176.50 and $184.38 during the session as investors weighed a string of CES updates tied to cars and PCs.

The moves land as CES 2026 opens in Las Vegas and suppliers try to convince investors they can turn artificial intelligence into revenue beyond smartphones. The trade show runs from Jan. 6 to 9 and is expected to feature autonomous-driving and AI-heavy pitches across the industry.

Qualcomm Technologies, a unit of Qualcomm, and Google said they expanded their decade-long automotive collaboration to help automakers build “software-defined vehicles” — cars that add and change features through software — and to bring “agentic AI,” software that can act on a driver’s behalf, into the cabin. Patrick Brady, a vice president of engineering at Google, said the companies were “thrilled to deepen” the partnership, while Qualcomm executive Nakul Duggal said it “marks a new chapter” in their work. MarketScreener

The expanded plan includes aligning Snapdragon Cockpit platforms with Android Automotive OS roadmaps starting with Android 17, and offering a Snapdragon virtual system-on-chip on Google Cloud’s Arm-based Axion instances to speed software development and testing. Qualcomm also outlined “Project Treble” for Android Automotive OS lifecycle management, aimed at making over-the-air updates — remote software updates — more predictable across multiple chip generations.

On the PC side, Qualcomm unveiled Snapdragon X2 Plus chips for Windows laptops, leaning on a built-in neural processing unit — a dedicated AI engine — that the company said can deliver up to 80 trillion operations per second, a common yardstick for AI acceleration. Kedar Kondap, a senior vice president at Qualcomm Technologies, said users want “power, efficiency and intelligence” without the trade-offs that can come with thin-and-light designs. Micro Center

Qualcomm spokesperson Cassandra Garcia-Bacha told The Verge that laptops using the Snapdragon X2 Elite and X2 Plus platforms should arrive around the end of the first quarter. Qualcomm executives also said they were aiming for similar price tiers to the prior generation as PC makers roll out CES lineups.

Qualcomm also used CES to broaden its edge-computing pitch, launching Dragonwing Q-series processors for Internet-of-Things devices meant to run AI on the device and pushing further into robotics. Mobile World Live reported the company was also showcasing a full-stack robotics architecture and targeting drones, smart cameras and industrial vision systems.

In autos, Qualcomm and supplier ZF also announced a driver-assistance tie-up that pairs ZF’s ProAI supercomputer with Qualcomm’s Snapdragon Ride chips, targeting systems that can scale up to Level 3 automated driving. “We’re enabling automakers to deliver intelligent, safer, and more cost-effective driver assistance systems,” Qualcomm’s Anshuman Saxena said.

But CES announcements do not always translate quickly into sales. Automotive and PC design cycles can stretch for quarters, and Qualcomm faces entrenched rivals in PCs such as Intel and AMD, while automotive compute remains crowded as suppliers compete for long-lived platforms.

Investors get the next hard catalyst on Feb. 4, when Qualcomm is scheduled to hold its fiscal first-quarter earnings conference call, with traders focused on guidance and how fast automotive and PC wins are converting into shipments.

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Applied Materials stock jumps to a fresh 52-week high as CES AI talk lifts chip-equipment shares
Previous Story

Applied Materials stock jumps to a fresh 52-week high as CES AI talk lifts chip-equipment shares

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope
Next Story

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope

Go toTop